Infective Endocarditis: A Case with Prolonged Fever
Versions
- 2021-09-30 (2)
- 2021-09-30 (1)
Downloads
Infective endocarditis (IE) is associated with a high rate of mortality and morbidity in patients with anomalies of heart valves. We present a case of a 23-year-old male known to have severe mitral regurgitation (MR) with a history of prolonged fever for 5 months. According to The Modified Duke Criteria, clinical sign and symptoms fulfilled one major criterion (echocardiography finding of vegetation on mitral valve) and three minor (fever of at least 380 Celsius, valvular heart disease as a predisposing heart condition, and positive blood culture for Lactococcus sp. and Pediococcus sp.) considered as definite IE. Fever is one of the most common symptoms of IE (>90% of cases). Patient with prolonged fever and structural abnormality of heart valve should be considered for acute or subacute of IE. Establishing an diagnosis of IE and appropriate antibiotic therapy will improve the patient's clinical condition, and reduce morbidity and mortality.
Keywords: Infective endocarditis (IE), Prolonged fever
Guler S, Sokmen A, Mese B and Bozoglan O. 2013. Infective endocarditis developing serious multiple complications BMJ Case Reports.
Sukmawati NM, Merati TP, Somia A, Utama S and Gayatri Y. 2018. Prolonged fever and involuntary weight loss as manifestations of bacterial endocarditis: A case report IOP Conference Series: Earth and Environmental Science; 125: 012-076.
Varghese G M, Trowbridge P and Doherty T. 2010. Investigating and managing pyrexia of unknown origin in adults BMJ 341.
Bleeker-Rovers C P, van der Meer JW and Oyen WJ. 2009. Fever of unknown origin Semi. Nucl. Med; 39: 81.
Vanderschueren S, Knockaert D, Adriaenssens T, Demey W, Durnez A, et al. 2003 Prolonged febrile illness to fever of unknown origin: the challenge continues Arch. Inter. Med. 163.
Prendergast B. 2015. Faculty of 1000 evaluation for 2015 ESC guidelines for the management of infective endocarditis: The task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). F1000 - Post-publication peer review of the biomedical literature.
Garbi M and Allen C. 2017. Faculty of 1000 evaluation for 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the american college of cardiology/american heart association task force on clinical practice guidelines. F1000 - Post-publication peer review of the biomedical literature.
Evangelista A, Gonzalez-Alujas M T. 2004. Echocardiography in infective endocarditis Heart: 614-617.
Rali A S, Al-Kofahi M, Patel N, Wiele B, Shah Z and Nath J. 2019. The full spectrum of infective endocarditis: Case report and review Case Reports in Cardiology: 1–4.
Georgountzos G, Michopoulos C, Grivokostopoulos C, Kolosaka M, Vlassopoulou N and Lekkou A. 2018. Infective endocarditis in a young adult due to Lactococcus lactis: A case report and review of the literature Case Reports in Medicine 2018: 1–4.
Copyright (c) 2021 Maulia Prismadani, Agus Subagjo
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Cardiovascular and Cardiometabolic Journal (CCJ) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
-
Authors who publish with Cardiovascular and Cardiometabolic Journal (CCJ) agree to the following terms:
-
The journal allows the author to hold the copyright of the article without restrictions.
-
The journal allows the author(s) to retain publishing rights without restrictions.
-
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA).
